This inventor holds 1 USPTO granted patent. Top assignee: Transtech Pharma, Inc.. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: John Dankwardt: Innovator in Pharmaceutical Chemistry
Introduction
John Dankwardt is a notable inventor based in Westborough, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can aid in the treatment of obesity-related disorders. His innovative work has led to the granting of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
John Dankwardt holds a patent for "Substituted heteroaryl derivatives, compositions, and methods of use." This invention provides substituted heteroaryl derivatives of Formula (I), along with methods for their preparation and pharmaceutical compositions that include these compounds. The compounds are designed to inhibit the action of AgRP on melanocortin receptors, which can be beneficial in managing and treating diseases responsive to the modulation of these receptors, particularly obesity-related disorders. He has 1 patent to his name.
Career Highlights
Dankwardt is associated with Transtech Pharma, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His career reflects a commitment to research and development, focusing on creating effective treatments for complex health issues.
Collaborations
Throughout his career, John has collaborated with talented professionals, including Bapu Reddy Gaddam and Robert Carl Andrews. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
John Dankwardt's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His work not only advances scientific knowledge but also holds the potential to improve the quality of life for many individuals facing health challenges.